Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
$0.22
$0.22
$0.17
$0.40
$6.47M0.521,980 shsN/A
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
$13.52
$8.80
$36.88
$8.65M0.83543,436 shs988,300 shs
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
$2.22
-1.8%
$2.17
$1.08
$3.79
$145.32M1.572.45 million shs91,807 shs
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
$2.82
-11.0%
$59,624.23
$0.75
$3.25
$15.03MN/A2.95 million shs464,394 shs
ULURU Inc. stock logo
ULUR
ULURU
$0.00
$0.10
$0.79
$5.35M-3.136,691 shsN/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
0.00%0.00%-6.36%-12.96%-40.61%
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
0.00%0.00%0.00%0.00%0.00%
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
-1.77%-5.13%-21.28%+74.80%+63.24%
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
-11.04%-46.79%-41.49%-40.00%+143.10%
ULURU Inc. stock logo
ULUR
ULURU
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
N/AN/AN/AN/AN/AN/AN/AN/A
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
N/AN/AN/AN/AN/AN/AN/AN/A
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
2.3609 of 5 stars
4.42.00.00.02.01.70.0
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
N/AN/AN/AN/AN/AN/AN/AN/A
ULURU Inc. stock logo
ULUR
ULURU
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
N/AN/AN/AN/A
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
N/AN/AN/AN/A
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
2.80
Moderate Buy$7.25226.58% Upside
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
N/AN/AN/AN/A
ULURU Inc. stock logo
ULUR
ULURU
N/AN/AN/AN/A

Current Analyst Ratings

Latest SBOT, ULUR, INBP, RGLS, and NTEC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/25/2024
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00
3/19/2024
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$12.00 ➝ $11.00
3/18/2024
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
3/18/2024
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00
3/18/2024
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$6.00
3/13/2024
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$2.00 ➝ $3.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
$50.67M0.13$0.04 per share5.75$0.63 per share0.34
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
N/AN/AN/AN/A$16.18 per shareN/A
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
N/AN/AN/AN/A$1.05 per shareN/A
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
$210K71.57N/AN/A$2.12 per share1.33
ULURU Inc. stock logo
ULUR
ULURU
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
-$30K-$0.01N/AN/A-0.76%-2.05%-1.47%5/6/2024 (Estimated)
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
-$14.13M-$16.32N/AN/AN/AN/A-96.37%-68.87%N/A
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
-$30.04M-$1.59N/AN/AN/AN/A-109.21%-80.55%5/9/2024 (Estimated)
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
-$5.03M-$1.76N/AN/AN/A-1,782.64%-51.12%-48.37%N/A
ULURU Inc. stock logo
ULUR
ULURU
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest SBOT, ULUR, INBP, RGLS, and NTEC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
-$0.40-$0.40N/A-$0.40N/AN/A
2/12/2024Q2 2024
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
N/A-$0.01-$0.01-$0.01N/A$11.51 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
N/AN/AN/AN/AN/A
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
N/AN/AN/AN/AN/A
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
N/AN/AN/AN/AN/A
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
N/AN/AN/AN/AN/A
ULURU Inc. stock logo
ULUR
ULURU
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
N/A
2.93
0.84
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
N/A
2.34
2.34
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
N/A
3.31
3.31
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
N/A
9.24
8.96
ULURU Inc. stock logo
ULUR
ULURU
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
25.25%
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
22.37%
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
92.38%
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
1.69%
ULURU Inc. stock logo
ULUR
ULURU
N/A

Insider Ownership

CompanyInsider Ownership
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
45.60%
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
3.30%
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
8.41%
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
7.80%
ULURU Inc. stock logo
ULUR
ULURU
1.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
14130.10 million16.37 millionNot Optionable
Intec Pharma Ltd stock logo
NTEC
Intec Pharma
40898,000N/AOptionable
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
3065.46 million59.96 millionOptionable
Stellar Biotechnologies Inc stock logo
SBOT
Stellar Biotechnologies
255.33 millionN/ANot Optionable
ULURU Inc. stock logo
ULUR
ULURU
230.57 million30.24 millionNot Optionable

SBOT, ULUR, INBP, RGLS, and NTEC Headlines

SourceHeadline
Better Homes & Gardens: April 26Better Homes & Gardens: April 26
tvtonight.com.au - April 24 at 5:24 AM
AAT Kings extends Australia and New Zealand guided vacations saleAAT Kings extends Australia and New Zealand guided vacations sale
travelweek.ca - April 23 at 2:23 PM
Five great walks in the Northern TerritoryFive great walks in the Northern Territory
australiangeographic.com.au - April 23 at 9:22 AM
What a modern retirement plan should look likeWhat a modern retirement plan should look like
smh.com.au - April 21 at 7:56 AM
Aussies ‘locked out’ of national parks to protect cultural heritageAussies ‘locked out’ of national parks to protect cultural heritage
news.com.au - April 21 at 7:56 AM
The rise of booze-free backpacking: why gen Z are choosing to travel soberThe rise of booze-free backpacking: why gen Z are choosing to travel sober
theguardian.com - April 21 at 7:56 AM
Bolt: Ban on non-Aborigines is the new apartheidBolt: Ban on non-Aborigines is the new apartheid
heraldsun.com.au - April 21 at 7:56 AM
Colin and Joh explore UluruColin and Joh explore Uluru
bhg.com.au - April 19 at 7:00 PM
The 11 Best Road Trips in the WorldThe 11 Best Road Trips in the World
outsideonline.com - April 18 at 4:50 AM
Truth-telling risks inflaming community conflict: reportTruth-telling risks inflaming community conflict: report
afr.com - April 18 at 4:50 AM
It’s political spending that feeds inflation, not Coles and WooliesIt’s political spending that feeds inflation, not Coles and Woolies
afr.com - April 18 at 4:50 AM
Truth, colonisation and Yoorrook: what is Victoria’s truth-telling inquiry and what will it achieve?Truth, colonisation and Yoorrook: what is Victoria’s truth-telling inquiry and what will it achieve?
theguardian.com - April 18 at 4:50 AM
Better Homes & Gardens: April 19Better Homes & Gardens: April 19
tvtonight.com.au - April 17 at 5:32 PM
LET THE GAMES BEGIN! REVERSE: 1999 FIRES OFF AUSTRALIA-THEMED VERSION 1.5 PHASE ONE UPDATE “REVIVAL! THE ULURU GAMES” TODAYLET THE GAMES BEGIN! REVERSE: 1999 FIRES OFF AUSTRALIA-THEMED VERSION 1.5 PHASE ONE UPDATE “REVIVAL! THE ULURU GAMES” TODAY
capsulecomputers.com.au - April 16 at 9:30 PM
Miguel Maestre teams up with Tourism NT and Luxury EscapesMiguel Maestre teams up with Tourism NT and Luxury Escapes
ntnews.com.au - April 15 at 8:22 PM
‘My kids were heartbroken over Bluey’s biggest episode’‘My kids were heartbroken over Bluey’s biggest episode’
adelaidenow.com.au - April 14 at 2:03 PM
The cost of marrying a British princeThe cost of marrying a British prince
msn.com - April 14 at 2:03 PM
Former soldier returns boomerang from nuclear test era to Maralingas traditional ownersFormer soldier returns boomerang from nuclear test era to Maralinga's traditional owners
msn.com - April 14 at 2:03 PM
It’s time to tick Uluru off your family adventure bucket listIt’s time to tick Uluru off your family adventure bucket list
ntnews.com.au - April 12 at 8:48 PM
The Inland Sea: An Australian OdysseyThe Inland Sea: An Australian Odyssey
avclub.com - April 12 at 8:55 AM
There’s nothing to sea here: Cruise dining goes inland for some spectacular new experiencesThere’s nothing to sea here: Cruise dining goes inland for some spectacular new experiences
msn.com - April 12 at 12:54 AM
Host a Screening of Living Black: Never Meant To HappenHost a Screening of Living Black: Never Meant To Happen
sbs.com.au - April 10 at 7:27 AM
Qantas launches surprise 72-hour flight sale to more than 60 domestic destinationsQantas launches surprise 72-hour flight sale to more than 60 domestic destinations
7news.com.au - April 9 at 11:26 AM
How to see the next 20 years of eclipses, including the eclipse of a lifetimeHow to see the next 20 years of eclipses, including the eclipse of a lifetime
msn.com - April 9 at 11:26 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Integrated BioPharma logo

Integrated BioPharma

OTCMKTS:INBP
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Intec Pharma logo

Intec Pharma

NASDAQ:NTEC
Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel.
Regulus Therapeutics logo

Regulus Therapeutics

NASDAQ:RGLS
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Stellar Biotechnologies logo

Stellar Biotechnologies

NASDAQ:SBOT
Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market. It provides its KLH protein under the Stellar KLH brand. The company's products include Stellar KLH protein in various grades, formulations, custom configurations, and fill finishes for drug development and research applications, as well as KLH-based in vitro diagnostic kits for research and preclinical use. Its customers and partners comprise biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers. Stellar Biotechnologies, Inc. is based in Port Hueneme, California.
ULURU logo

ULURU

OTCMKTS:ULUR
ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. was founded in 1987 and is based in Addison, Texas.